Table 1 Frequency of primary lung cancer cases with 1+/10+ cytoplasmic mucin inclusions in a tissue microarray core and range of number of mucin inclusions (in parenthesis).
Diagnosis | No. of cases | PASD | ABPAS | Mucicarmine |
|---|---|---|---|---|
Adenocarcinoma | 416 | 81%/51% (0–10+) | 78%/48% (0–10+) | 58%/31% (0–10+) |
Squamous cell carcinoma | 194 | 11%/2.6% (0–10+) | 9.8%/4.1% (0–10+) | 4.6%/0.5% (0–10+) |
Large cell carcinoma | 8 | 38%/0% (0–5) | 38%/0% (0–6) | 13%/0% (0–1) |
Sarcomatoid carcinoma | 6 | 50%/50% (0–10+) | 50%/50% (0–10+) | 50%/33% (0–10+) |
Small cell carcinoma | 3 | 0%/0% (0) | 0%/0% (0) | 0%/0% (0) |
Large cell neuroendocrine carcinoma | 23 | 4.3%/0% (0–1) | 0%/0% (0) | 0%/0% (0) |
Carcinoid tumor | 7 | 0%/0% (0) | 0%/0% (0) | 0%/0% (0) |
All | 657 | 56%/34% (0–10+) | 53%/32% (0–10+) | 39%/20% (0–10+) |
